Follow
Andrea Alimonti
Andrea Alimonti
IOR
Verified email at ior.USI.ch
Title
Cited by
Cited by
Year
Cellular senescence: defining a path forward
V Gorgoulis, PD Adams, A Alimonti, DC Bennett, O Bischof, C Bishop, ...
Cell 179 (4), 813-827, 2019
17622019
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer
A Carracedo, L Ma, J Teruya-Feldstein, F Rojo, L Salmena, A Alimonti, ...
The Journal of clinical investigation 118 (9), 3065-3074, 2008
16622008
Ubiquitination regulates PTEN nuclear import and tumor suppression
LC Trotman, X Wang, A Alimonti, Z Chen, J Teruya-Feldstein, H Yang, ...
Cell 128 (1), 141-156, 2007
9032007
NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN
X Wang, LC Trotman, T Koppie, A Alimonti, Z Chen, Z Gao, J Wang, ...
Cell 128 (1), 129-139, 2007
8312007
Cellular senescence: aging, cancer, and injury
A Calcinotto, J Kohli, E Zagato, L Pellegrini, M Demaria, A Alimonti
Physiological reviews 99 (2), 1047-1078, 2019
8112019
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
BS Carver, J Tran, A Gopalan, Z Chen, S Shaikh, A Carracedo, A Alimonti, ...
Nature genetics 41 (5), 619-624, 2009
7762009
Subtle variations in Pten dose determine cancer susceptibility
A Alimonti, A Carracedo, JG Clohessy, LC Trotman, C Nardella, A Egia, ...
Nature genetics 42 (5), 454-458, 2010
6782010
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N= 4532)
M Montopoli, S Zumerle, R Vettor, M Rugge, M Zorzi, CV Catapano, ...
Annals of Oncology 31 (8), 1040-1045, 2020
5902020
Pro-senescence therapy for cancer treatment
C Nardella, JG Clohessy, A Alimonti, PP Pandolfi
Nature Reviews Cancer 11 (7), 503-511, 2011
5042011
PML inhibits HIF-1α translation and neoangiogenesis through repression of mTOR
R Bernardi, I Guernah, D Jin, S Grisendi, A Alimonti, J Teruya-Feldstein, ...
Nature 442 (7104), 779-785, 2006
4762006
Identification of a tumour suppressor network opposing nuclear Akt function
LC Trotman, A Alimonti, PP Scaglioni, JA Koutcher, C Cordon-Cardo, ...
Nature 441 (7092), 523-527, 2006
4602006
A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis
A Alimonti, C Nardella, Z Chen, JG Clohessy, A Carracedo, LC Trotman, ...
The Journal of clinical investigation 120 (3), 681-693, 2010
4132010
Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity
A Toso, A Revandkar, D Di Mitri, I Guccini, M Proietti, M Sarti, S Pinton, ...
Cell reports 9 (1), 75-89, 2014
4002014
Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer
D Di Mitri, A Toso, JJ Chen, M Sarti, S Pinton, TR Jost, R D’Antuono, ...
Nature 515 (7525), 134-137, 2014
3512014
PTEN level in tumor suppression: how much is too little?
A Carracedo, A Alimonti, PP Pandolfi
Cancer research 71 (3), 629-633, 2011
3092011
IL-23 secreted by myeloid cells drives castration-resistant prostate cancer
A Calcinotto, C Spataro, E Zagato, D Di Mitri, V Gil, M Crespo, ...
Nature 559 (7714), 363-369, 2018
3062018
Zoledronic-acid-induced circulating level modifications of angiogenic factors, metalloproteinases and proinflammatory cytokines in metastatic breast cancer patients
G Ferretti, A Fabi, P Carlini, P Papaldo, P Cordiali Fei, S Di Cosimo, ...
Oncology 69 (1), 35-43, 2005
2082005
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer
DN Rodrigues, P Rescigno, D Liu, W Yuan, S Carreira, MB Lambros, ...
The Journal of clinical investigation 128 (10), 4441-4453, 2018
2022018
mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer
A Zabala-Letona, A Arruabarrena-Aristorena, N Martín-Martín, ...
Nature 547 (7661), 109-113, 2017
1752017
New approaches to prevent intestinal toxicity of irinotecan-based regimens
A Alimonti, A Gelibter, I Pavese, F Satta, F Cognetti, G Ferretti, D Rasio, ...
Cancer treatment reviews 30 (6), 555-562, 2004
1712004
The system can't perform the operation now. Try again later.
Articles 1–20